跳至主要内容
临床试验/NCT05035017
NCT05035017已完成不适用

Clinical Validation of the Apollo Daily Disposable Soft Contact Lenses

Coopervision, Inc.2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2021年6月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
2
主要终点
Overall Comfort With Lens

研究概览

简要总结

The purpose of this study was to confirm the design specifications of a Test lens and validate its clinical performance.

详细描述

This was a double-masked, randomized, bilateral two-day crossover, dispensing study design. Subjects were randomized to wear the Test lens or Control lens bilaterally in random order and on a daily wear, single-use basis for a period of 2 days each.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Has had a self-reported oculo-visual examination in the last two years.
  • Is at least 18 years of age and has full legal capacity to volunteer.
  • Has read and understood the information consent letter.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Is an adapted soft contact lens wearer, having worn contact lenses for a minimum 4 weeks prior to the study
  • Has spectacle cylinder ≤1.00D in both eyes.
  • Has spherical contact lens power requirement between -1.00D and -6.00D in both eyes.
  • Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/20 in each eye.
  • Wears CLs in both eyes (monovision acceptable, but not monofit)
  • Has clear corneas and no active ocular disease.
  • Has not worn lenses for at least 12 hours before the examination
  • Is willing to wear the study contact lenses for a minimum 8 hours on at least two consecutive days for each study pair.

排除标准

  • Has never worn contact lenses before.
  • Has any systemic disease affecting ocular health.
  • Is using any concomitant systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
  • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Is aphakic.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of eye-related clinical or research study.

结局指标

主要结局

Overall Comfort With Lens

时间窗: 2 days

Participants rated their overall comfort once after 2 days of wear a 0-100 integer scale, where 0=Cannot be tolerated and 100=Excellent comfort.

次要结局

  • Overall Lens Handling(2 days)
  • Overall Vision Quality(2 days)
  • Overall Lens Fit Acceptance(2 days)
  • Anterior Ocular Health - Corneal Staining Extent(2 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Clinical Validation of the Apollo Daily Disposable... | 临床试验